Clinical Trial

Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Aspirin group: Aspirin 100mg will be started within 24 hours after randomization, and continued aspirin 100mg/day the end of the study period. Non-antithrombotic group: No antithrombotic agents will be administered after randomization until the end of the study period.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-08-17.
Trial Details
NCT Number NCT06007222
Lead Sponsor OCEAN-SHD Study Group
Conditions Aortic Stenosis, TAVI(Transcatheter Aortic Valve Implantation), Aspirin, DAPT(Dual Antiplatelet Therapy), SAPT(Single Antiplatelet Therapy)
Enrollment 400 participants
Start Date 2023-04-06
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-09-23